Proprioceptive Deficits in Degenerative Cervical Myelopathy
Early Detection of Proprioceptive Dysfunction in Degenerative Cervical Myelopathy by Proprioceptive Functional Analysis in Activities of Daily Living
1 other identifier
observational
100
1 country
1
Brief Summary
Proprioceptive deficits in degenerative cervical myelopathy (DCM) is a progressive neurological deficits in somatosensory and motor function which affects the body balance and motor control. DCM usually presents with body incoordination, hand clumsiness and gait disturbance associated with proprioceptive dysfunction that hinders the physical performance and functions. In this study, a non-invasive assessment protocol on proprioception will be developed for detecting subtle proprioceptive deficits at the early stage of disease through simple Physical Performance Tests for population older than 45. By adopting the physical performance tests as the diagnostic predictors of DCM, we aim to avoid the development of devastating consequences and disabilities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 14, 2021
CompletedFirst Posted
Study publicly available on registry
January 11, 2022
CompletedStudy Start
First participant enrolled
September 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2035
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2036
July 11, 2024
June 1, 2024
13.1 years
December 14, 2021
July 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Modified Japanese Orthopaedics Association Scoring System for Cervical Myelopathy (mJOA)
mJOA is a self-reported functional questionnaire on disease severity through assessing 4 domains: 1. Upper Limb Function 2. Lower Limb Function 3. Sensory Function 4. Bladder Function mJOA has a total score of 17 and it categories DCM patient into different severity as below: 1. Mild \>= 15 2. Moderate = 12-14 3. Severe \< 12
15 years
Secondary Outcomes (2)
Proprioceptive Deficits - Speed Test
15 years
Proprioceptive Deficits - Time Limited Test
15 years
Study Arms (2)
(1) Degenerative Cervical Myelopathy
Chinese subjects aged 50 or above who have radiological evidence of Degenerative Cervical Myelopathy, symptomatic with Nurick Grade less than 3 will be included.
(2) Healthy Controls
Chinese healthy controls aged 50 or above who have no myelopathic signs of Degenerative Cervical Myelopathy with Nurick Grade less than 3 will be included.
Interventions
Proprioceptive testing and Physical Performance Tests
Eligibility Criteria
Radiologically confirmed with Degenerative Cervical Myelopathy
You may qualify if:
- Chinese
- Aged 50 or above
- With radiological evidence of degenerative cervical myelopathy, both symptomatic and asymptomatic
- Nurick grade less than 3
You may not qualify if:
- Non-Chinese ethnicity
- Aged under 50
- without any radiological proof of cervical myelopathy
- Active problems of tuberculosis spine, lumbar spinal diseases, and other problems causing pain or deformities over the limbs that may affect their balance and movement
- Presents with extra-pyramidal or other disorders involving the cerebellum or frontal lobe of the cerebrum leading to poor balance and gait disturbance
- Previous spinal operation with residual disturbance in balance or gait
- Non-communicable patients with insufficient cognitive ability to express their symptoms clearly
- Non-walker
- Blind or deaf
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Duchess of Kent Children's Hospital at Sandy Bay
Hong Kong, 000, Hong Kong
Study Officials
- PRINCIPAL INVESTIGATOR
Karlen Ka Pui Law, M. Phil
The University of Hong Kong
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 14, 2021
First Posted
January 11, 2022
Study Start
September 1, 2022
Primary Completion (Estimated)
September 30, 2035
Study Completion (Estimated)
September 30, 2036
Last Updated
July 11, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share
Data should not be shared with other researchers